BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 25776842)

  • 1. Chemokine-mediated immune responses in the female genital tract mucosa.
    Deruaz M; Luster AD
    Immunol Cell Biol; 2015 Apr; 93(4):347-54. PubMed ID: 25776842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women.
    Agrawal T; Vats V; Salhan S; Mittal A
    J Reprod Immunol; 2009 Dec; 83(1-2):173-8. PubMed ID: 19896206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination.
    Bagri P; Anipindi VC; Nguyen PV; Vitali D; Stämpfli MR; Kaushic C
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells.
    Quayle AJ
    J Reprod Immunol; 2002; 57(1-2):61-79. PubMed ID: 12385834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant multivalent combination vaccine protects against Chlamydia and genital herpes.
    Macmillan L; Ifere GO; He Q; Igietseme JU; Kellar KL; Okenu DM; Eko FO
    FEMS Immunol Med Microbiol; 2007 Feb; 49(1):46-55. PubMed ID: 17094789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract.
    Rebbapragada A; Wachihi C; Pettengell C; Sunderji S; Huibner S; Jaoko W; Ball B; Fowke K; Mazzulli T; Plummer FA; Kaul R
    AIDS; 2007 Mar; 21(5):589-98. PubMed ID: 17314521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of mucosal immunity in preventing genital herpes infection.
    MasCasullo V; Fam E; Keller MJ; Herold BC
    Viral Immunol; 2005; 18(4):595-606. PubMed ID: 16359226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Male genital tract immune response against
    Mackern-Oberti JP; Motrich RD; Damiani MT; Saka HA; Quintero CA; Sánchez LR; Moreno-Sosa T; Olivera C; Cuffini C; Rivero VE
    Reproduction; 2017 Oct; 154(4):R99-R110. PubMed ID: 28878094
    [No Abstract]   [Full Text] [Related]  

  • 10. Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines.
    He Q; Martinez-Sobrido L; Eko FO; Palese P; Garcia-Sastre A; Lyn D; Okenu D; Bandea C; Ananaba GA; Black CM; Igietseme JU
    Immunology; 2007 Sep; 122(1):28-37. PubMed ID: 17451464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrin α4β1 is necessary for CD4+ T cell-mediated protection against genital Chlamydia trachomatis infection.
    Davila SJ; Olive AJ; Starnbach MN
    J Immunol; 2014 May; 192(9):4284-93. PubMed ID: 24659687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus-2 in the genital mucosa: insights into the mucosal host response and vaccine development.
    Lee AJ; Ashkar AA
    Curr Opin Infect Dis; 2012 Feb; 25(1):92-9. PubMed ID: 22143115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.
    Sturdevant GL; Caldwell HD
    Pathog Dis; 2014 Oct; 72(1):70-3. PubMed ID: 24585717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSV-2 vaccine: current state and insights into development of a vaccine that targets genital mucosal protection.
    Roth K; Ferreira VH; Kaushic C
    Microb Pathog; 2013 May; 58():45-54. PubMed ID: 23159485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV infection in the female genital tract: discrete influence of the local mucosal microenvironment.
    Kaushic C; Ferreira VH; Kafka JK; Nazli A
    Am J Reprod Immunol; 2010 Jun; 63(6):566-75. PubMed ID: 20384619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-secreting eosinophils promote endometrial stromal cell proliferation and prevent
    Vicetti Miguel RD; Quispe Calla NE; Dixon D; Foster RA; Gambotto A; Pavelko SD; Hall-Stoodley L; Cherpes TL
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6892-E6901. PubMed ID: 28765368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian steroid hormones: effects on immune responses and Chlamydia trachomatis infections of the female genital tract.
    Hafner LM; Cunningham K; Beagley KW
    Mucosal Immunol; 2013 Sep; 6(5):859-75. PubMed ID: 23860476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract.
    Tang VA; Rosenthal KL
    J Reprod Immunol; 2010 Dec; 87(1-2):39-44. PubMed ID: 20688399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal immunity in the HSV-2 mouse model.
    Parr MB; Parr EL
    Int Rev Immunol; 2003; 22(1):43-63. PubMed ID: 12710503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.